AbbVie 2013 Annual Report Download - page 63

Download and view the complete annual report

Please find page 63 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

AbbVie Inc. and Subsidiaries
Consolidated Balance Sheets
as of December 31 (in millions, except share data) 2013 2012
Assets
Current assets
Cash and equivalents $ 9,595 $ 5,901
Short-term investments 300 2,075
Accounts and other receivables, net 3,854 4,298
Inventories, net 1,150 1,091
Income tax receivable 949
Deferred income taxes 766 669
Prepaid expenses and other 1,234 1,320
Total current assets 17,848 15,354
Investments 118 119
Property and equipment, net 2,298 2,247
Intangible assets, net of amortization 1,890 2,323
Goodwill 6,277 6,130
Other assets 767 835
Total assets $29,198 $27,008
Liabilities and Equity
Current liabilities
Short-term borrowings $ 413 $ 1,020
Current portion of long-term debt and lease obligations 18 22
Accounts payable and accrued liabilities 6,448 5,734
Total current liabilities 6,879 6,776
Long-term liabilities 3,535 2,239
Long-term debt and lease obligations 14,292 14,630
Commitments and contingencies
Equity
Net parent company investment in AbbVie Inc., prior to separation 3,713
Stockholders’ equity
Common stock, $0.01 par value, authorized 4,000,000,000 shares, issued
1,594,260,996 shares in 2013 16
Common stock held in treasury, at cost, 6,900,434 shares in 2013 (320)
Additional paid-in-capital 3,671
Retained earnings 1,567
Accumulated other comprehensive loss (442) (350)
Total stockholders’ equity 4,492 (350)
Total equity 4,492 3,363
Total liabilities and equity $29,198 $27,008
The accompanying notes are an integral part of these consolidated financial statements.
59